Illumina, Inc. vs Shopify Inc. — how do they compare? Illumina, Inc. trades at $278 (market cap $39.95B), while Shopify Inc. trades at $170.62 (market cap $211.73B). The key difference: Shopify Inc. is far larger — about 5.3× Illumina, Inc.'s market cap, and Shopify Inc. is more actively traded (7,146,651 versus 3,169,503). Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Shopify Inc. for 78 Days on average.
| ILMN | SHOP | |
|---|---|---|
Market Cap | $39.95B | $211.73B |
Volume | 3,169,503 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $293.69 | $179.01 |
52-Week Low | $91.00 | $95.40 |
Typical Hold Time | 83 Days | 78 Days |
Enterprise Value | $41.31B | $206.96B |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $278.17, up 3.89% today and near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent inclusion in the S&P 500 and positive analyst upgrades reflect growing institutional confidence. Revenue remains stable at $4.34B for 2025 with improved profitability, delivering $850M net income after previous losses.
The outlook remains positive with sequencing growth and AI initiatives driving momentum, though elevated valuation ratios and China market headwinds present risks. Analyst consensus leans bullish with 54% buy ratings, but the current price exceeds the $241 consensus target, suggesting near-term consolidation potential before further upside.
Shopify (SHOP) trades at $170.85, up 2.96% today, showing strong momentum near its 52-week high. The stock exhibits bullish technical signals with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, Shopify demonstrates robust revenue growth from $5.6B in 2022 to $11.6B in 2025, with net income turning positive and reaching $1.23B. Recent earnings show mixed results with one miss and two beats in the last three quarters.
Shopify's outlook remains positive with accelerating merchant solutions growth and AI innovations, though elevated valuation metrics (P/E of 111.19) present risk. Analyst consensus is strongly bullish with 67% buy ratings and $168.63 price target. Key risks include competitive pressures from Amazon and valuation sensitivity to growth expectations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →